A Baylor College of Medicine–led team is raising awareness about applying the widely used values of insulin dose-adjusted hemoglobin A1c (IDAA1c) when screening for partial type 1 diabetes remission in youth with overweight or obesity. The study appeared in Diabetes Care.
Common type 1 diabetes score misses over half of partial remissions in youth with overweight or obesity
This article discusses a medical study from Baylor College of Medicine about type 1 diabetes screening in youth with overweight or obesity, published in Diabetes Care. The research has no direct connection to Iran, Iranian politics, or Iranian affairs.
👥 Key Players
📰 What Happened
Researchers at Baylor College of Medicine found that a commonly used diagnostic score (IDAA1c) for detecting partial remission of type 1 diabetes fails to identify over half of remission cases in young people who are overweight or obese. The study suggests the current screening method is inadequate for this specific population and raises awareness about the need for improved diagnostic approaches.
- The IDAA1c score misses more than 50% of partial remission cases in youth with overweight/obesity
- This is a medical/health research finding with no Iran-related content
- The study was published in the peer-reviewed journal Diabetes Care
💡 Why It Matters
📚 Background
Type 1 diabetes is an autoimmune condition where the body attacks insulin-producing cells. Partial remission occurs when the body temporarily regains some ability to produce insulin. The IDAA1c score combines hemoglobin A1c (blood sugar control measure) with insulin dosage to assess remission status.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%